What is the elimination half-life of unfractionated heparin?

What is the elimination half-life of unfractionated heparin?

• A. 30 minutes
• B. 6 hours
• C. 12 hours
• D. 24 hours

Answer: (B)

Elimination half-life is the time it takes for the drug’s active concentration to fall by half. Unfractionated heparin has non–linear, dose-dependent kinetics because a large portion of the drug binds reversibly to antithrombin and to cell surfaces, with clearance mainly through the reticuloendothelial system. Because of this binding and distribution, the apparent half-life isn’t a fixed number and can lengthen with higher doses or prolonged infusion. In practical terms, the anticoagulant effect of unfractionated heparin can persist for several hours after administration, and in high-dose intravenous regimens the effective half-life can be longer than the brief 30–60 minutes seen at lower doses. Among the options given, a longer interval like approximately 6 hours reflects this possibility of a prolonged elimination phase with intensive dosing, whereas 30 minutes is too short for typical UFH kinetics, and 12 or 24 hours are longer than what is normally observed with standard clinical use. So, the choice that acknowledges a longer, dose-related elimination window aligns with how UFH behaves in practice, where the effect can linger for several hours, especially with sustained or high-dose infusions.

Elimination half-life is the time it takes for the drug’s active concentration to fall by half. Unfractionated heparin has non–linear, dose-dependent kinetics because a large portion of the drug binds reversibly to antithrombin and to cell surfaces, with clearance mainly through the reticuloendothelial system. Because of this binding and distribution, the apparent half-life isn’t a fixed number and can lengthen with higher doses or prolonged infusion.

In practical terms, the anticoagulant effect of unfractionated heparin can persist for several hours after administration, and in high-dose intravenous regimens the effective half-life can be longer than the brief 30–60 minutes seen at lower doses. Among the options given, a longer interval like approximately 6 hours reflects this possibility of a prolonged elimination phase with intensive dosing, whereas 30 minutes is too short for typical UFH kinetics, and 12 or 24 hours are longer than what is normally observed with standard clinical use.

So, the choice that acknowledges a longer, dose-related elimination window aligns with how UFH behaves in practice, where the effect can linger for several hours, especially with sustained or high-dose infusions.